Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2008 | 1 |
2010 | 1 |
2011 | 1 |
2012 | 2 |
2014 | 1 |
2024 | 1 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer.
N Engl J Med. 2024 Mar 7;390(10):875-888. doi: 10.1056/NEJMoa2312117.
N Engl J Med. 2024.
PMID: 38446675
Clinical Trial.
Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study.
Fizazi K, Scher HI, Molina A, Logothetis CJ, Chi KN, Jones RJ, Staffurth JN, North S, Vogelzang NJ, Saad F, Mainwaring P, Harland S, Goodman OB Jr, Sternberg CN, Li JH, Kheoh T, Haqq CM, de Bono JS; COU-AA-301 Investigators.
Fizazi K, et al.
Lancet Oncol. 2012 Oct;13(10):983-92. doi: 10.1016/S1470-2045(12)70379-0. Epub 2012 Sep 18.
Lancet Oncol. 2012.
PMID: 22995653
Clinical Trial.
Item in Clipboard
Phase II clinical trial of PM00104 (Zalypsis(®)) in urothelial carcinoma patients progressing after first-line platinum-based regimen.
Castellano DE, Bellmunt J, Maroto JP, Font-Pous A, Morales-Barrera R, Ghanem I, Suarez C, Martín Lorente C, Etxaniz O, Capdevila L, Coronado C, Alfaro V, Siguero M, Fernández-Teruel C, Carles J.
Castellano DE, et al. Among authors: font pous a.
Cancer Chemother Pharmacol. 2014 Apr;73(4):857-67. doi: 10.1007/s00280-014-2419-7. Epub 2014 Feb 26.
Cancer Chemother Pharmacol. 2014.
PMID: 24570330
Clinical Trial.
Item in Clipboard
[Renal-cell carcinoma and multiple mieloma: synchronic association with posible immunologic pathogenesis].
Cuadra-Urteaga JL, Font Pous A, Pardo-Aranda N, Rocafiguera AO.
Cuadra-Urteaga JL, et al. Among authors: font pous a.
Med Clin (Barc). 2012 Mar 3;138(5):224-5. doi: 10.1016/j.medcli.2011.04.029. Epub 2011 Jun 29.
Med Clin (Barc). 2012.
PMID: 21719048
Spanish.
No abstract available.
Item in Clipboard
SEOM clinical guidelines for the treatment of small-cell lung cancer.
Artal Cortés A, Dómine Gómez M, Font Pous A, García Campelo R, Cobo Dolls M, Isla Casado D; SEOM.
Artal Cortés A, et al. Among authors: font pous a.
Clin Transl Oncol. 2010 Jan;12(1):27-31. doi: 10.1007/s12094-010-0463-2.
Clin Transl Oncol. 2010.
PMID: 20080468
No abstract available.
Item in Clipboard
[Study of effectiveness of 3 schedules of administration of erythropoietic colony-stimulating factors in anemic patients under chemotherapy for solid or hematology malignancy].
Pontón Sivillá JL, Feliu Frasnedo E, Modamio Charles P, Mariño Hernández EL, Font Pous A, Lezcano Rubio C, Ribera Santasusana JM, Bonafont Pujol X.
Pontón Sivillá JL, et al. Among authors: font pous a.
Med Clin (Barc). 2008 Oct 11;131(12):447-51. doi: 10.1157/13126953.
Med Clin (Barc). 2008.
PMID: 18928734
Spanish.
Item in Clipboard
Cite
Cite